Drug Type Universal CAR-T |
Synonyms BRL302 |
Target |
Mechanism BCMA modulators(B-cell maturation protein modulators) |
Therapeutic Areas |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
AQP4-IgG positive Neuromyelitis optica spectrum disorder | Phase 1 | - | 25 Nov 2024 | |
Castration-Resistant Prostatic Cancer | Preclinical | CN | 30 Jan 2022 |